向日葵大健康因收购兮璞材料事项收深交所关注函 要求说明产能及诉讼等问题

Core Viewpoint - Shenzhen Stock Exchange's ChiNext Market has issued an inquiry letter to Zhejiang Sunflower Health Technology Co., Ltd. regarding its asset acquisition plan, particularly focusing on the operational status of its target company, Xipu Materials Technology Co., Ltd. [1] Group 1: Inquiry Areas - The inquiry letter addresses the actual production capacity and status of Xipu Materials, which claims to be a core supplier for semiconductor manufacturers but has been reported to lack actual production capacity at its facilities [1][2] - It requests detailed financial information regarding Xipu Materials' product revenues, costs, and gross margins for 2023 and 2024, as well as specifics on its procurement of electronic fluorinated liquids [2] - The letter seeks clarification on whether the acquisition will introduce new competition or related party transactions that could adversely affect the company's independence [2] - It also inquires about the legal issues faced by Xipu Materials' actual controller, Chen Chaoqi, and their potential impact on the company's operations and asset transfer [2][3] Group 2: Compliance and Responsibilities - The independent financial advisor of Sunflower Health is required to verify the information and provide clear opinions on the matters raised [3] - The company is reminded of its obligation to disclose information accurately and completely, with all board members held accountable for any misrepresentation or omissions [3]